MAT1A anticorps (N-Term)
-
- Antigène Voir toutes MAT1A Anticorps
- MAT1A (Methionine Adenosyltransferase I, alpha (MAT1A))
-
Épitope
- N-Term
-
Reactivité
- Humain, Souris, Rat, Chien, Drosophila melanogaster, C. elegans
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp MAT1A est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC)
- Specificité
- MAT1 A antibody was raised against the N terminal of MAT1
- Purification
- Purified
- Immunogène
- MAT1 A antibody was raised using the N terminal of MAT1 corresponding to a region with amino acids TSESVGEGHPDKICDQISDAVLDAHLKQDPNAKVACETVCKTGMVLLCGE
- Top Product
- Discover our top product MAT1A Anticorps primaire
-
-
- Indications d'application
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
MAT1A Blocking Peptide, catalog no. 33R-9282, is also available for use as a blocking control in assays to test for specificity of this MAT1A antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of MAT0 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- MAT1A (Methionine Adenosyltransferase I, alpha (MAT1A))
- Autre désignation
- MAT1A (MAT1A Produits)
- Synonymes
- anticorps MAT, anticorps MATA1, anticorps SAMS, anticorps SAMS1, anticorps AdoMet, anticorps SADE, anticorps SAS, anticorps AI046368, anticorps Ams, anticorps wu:fi35e01, anticorps zgc:55442, anticorps methionine adenosyltransferase 1A, anticorps methionine adenosyltransferase I, alpha, anticorps MAT1A, anticorps Mat1a, anticorps mat1a
- Sujet
- MAT1A catalyzes the formation of S-adenosylmethionine from methionine and ATP. Methionine adenosyltransferase deficiency is caused by recessive and dominant mutations, the latter identified in autosomal dominant persistant hypermethioninemia.
- Poids moléculaire
- 43 kDa (MW of target protein)
- Pathways
- Mitotic G1-G1/S Phases, M Phase, Ribonucleoside Biosynthetic Process, Methionine Biosynthetic Process
-